Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T19:58:07.143Z.
Calculation as of: 2026-10-06T19:58:07.143Z.
Quote observation: 2026-10-06T19:55:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2d3a9198413857e44d8ff08287218970dc762668c083e85858692cc7a401d48f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Neonc Technologies Holdings, Inc.
Market Cap
$76.50M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$75.82M
Price/FCF Ratio
4.56
TTM Avg
5.17
3Y Avg
25.10
5Y Avg
25.10
Market Cap
$77.73M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.98M
Price/FCF Ratio
N/A
TTM Avg
786.60
3Y Avg
786.60
5Y Avg
786.60
Market Cap
$73.10M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | $76.50M | N/A | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $75.82M | 4.56 | 5.17 | 25.10 | 25.10 |
| Outset Medical, Inc. (OM)vs › | $76.84M | N/A | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $75.18M | N/A | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.72M | N/A | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $77.73M | N/A | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $73.77M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $77.98M | N/A | 786.60 | 786.60 | 786.60 |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $73.10M | N/A | N/A | N/A | N/A |
| vTv Therapeutics Inc. (VTVT)vs › | $79.11M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
